South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt
Asyut, 0020, Egypt
NCT Number: NCT04342065
The anti-epileptic drugs such as gabapentin and other non-steroidal anti-inflammatory drugs (NSAID) such as celecoxib were used as a part of multimodal analgesia to control such pain. Gabapentin is an anticonvulsant drug that has analgesic effect in post-herpetic neuralgia, diabetic neuropathy, and neuropathic pain. Celecoxib is one of the NSAIDs, that its analgesic effect is reported in various studies by cyclooxygenase-2 (COX-2) inhibitor.
The aim of this randomized double-blinded study was to asses and compare the efficacy of using gabapentin versus celecoxib as a part of multimodal analgesia in perioperative hemodynamic control and pain relief in patients underwent posterior approach lumbar spine disc fixation surgery.
Looking for future studies?
Notify Me21 year–60 year
All sexes
Interventional
Phase 2 / Phase 3
Asyut, 0020, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
received celecoxib 200 mg 2 hours preoperative and the same dose 6 hours postoperative.
received Pregabalin 150mg 2 hours preoperative and the same dose 6 hours postoperative.
Time frame: Change from Baseline Visual Analogue Scale every 4 hours for 48 hours (0=no pain 10=most sever pain)
Visual Analogue Scale for pain measurement.
South Egypt Cancer Institute
Other
Efficacy of Pre-emptive Different Doses of Oral Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Patients Subjected for Elective Lumbar Spine Fixation Surgery: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01307215
Neurologic Manifestations, Pain
Hamilton, Ontario, Canada
View Trial DetailsNCT05831449
Bunion, Foot Deformities
Salt Lake City, Utah, United States
View Trial DetailsNCT06028126
Anesthesia, Local, Chemically-Induced Disorders
Calgary, Alberta, Canada
View Trial DetailsNCT07418671
Erector Spinae Plane Block, Neurologic Manifestations
Cairo, Cairo Governorate, Egypt
View Trial Details